Immunology

Biosensors for COVID-19

Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it.

Do antibiotics reach bacteria hiding in tissues?

Scientists have developed a new imaging method to see where antibiotics have reached bacteria within tissues.

Delighting in the negative

Sarah May, Deputy Chief Executive of the IBMS, wonders at our apparent inability to celebrate success.

The vaccine race

With more than 150 COVID-19 vaccines in development, we put the three front-runners under the microscope and look at the incredible, unprecedented development work of the last year.

Smallpox, salmonella and sacrifice

Stephen Mortlock looks back at the history of the Aztec civilisation, the diseases that struck and the treatments that were created.

Urgent need for early COVID-19 treatments

COVID-19 treatments for people with early infection are needed urgently, according to Anthony S Fauci, Director of the US National Institute of Allergy and Infectious Diseases.

What is long COVID?

Dr David Strain, a Senior Clinical Lecturer, is heading up the British Medical Association’s work on the long-term impact of COVID-19. Here he explains what we know so far about long COVID.

New biomarker to prevent graft-versus-host disease

A recent report sheds light on immune cell biomarkers that may reveal which patients are most at risk for graft-versus-host disease (GVHD).

Air pollution and COVID-19

Scientists have found that long-term exposure to urban air pollution may have made COVID-19 more deadly.

COVID-19 not characterised by a cytokine storm

Inflammatory proteins known as cytokines play a crucial role in the immune response. If this response is too strong – a phenomenon known as “cytokine storm” – it can cause harm to the patient.

Top